MKI67 and neoplasm: In addition, in the subgroups of patients whose tumor size ≥5 cm, mitoses II and III, Ki67 classification II and III or in NIH invasion III, IV and V, the DFS of CCBE1 low expression group was also superior to that of CCBE1 high expression group (Fig. 4C–F).